Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
THAP domain-containing protein 2 belongs to the human THAP protein family, defined by its N-terminal THAP domain—a zinc-dependent DNA-binding motif structurally related to the C2CH zinc finger family[1][3][5]. The THAP domain is around 90 amino acids in length and coordinates a zinc ion, conferring sequence-specific DNA binding potential. THAP2 is thought to participate in DNA regulation and may be involved in biological processes such as cell proliferation, apoptosis, and cell cycle modulation, although definitive functional roles of THAP2 remain to be elucidated[1][2][5][7]. Diseases associated with THAP2 include ophthalmia nodosa and periarthritis, but there is limited understanding of its mechanistic involvement[4]. Unlike some THAP family members (e.g., THAP1), specific molecular interactions or pathogenic roles have not been well described for THAP2.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on THAP domain-containing protein 2 (THAP2).